Weight Loss Injection Costs UK from £135.00 | Cured Pharmacy
Weight Loss Injection Costs - UK's Lowest Prices
Takes less than 2 minutes to complete 100% online
Our Pricing
Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.
Mounjaro Weight Loss Injections (Tirzepatide) KwikPen
Wegovy (Semaglutide) Weight Loss Injection
Wegovy® Oral Tablets (Semaglutide Pill)
Weight Loss Injection Costs - UK's Lowest Prices
Published on: June 03, 2026
Understanding weight loss injection costs uk is essential when choosing the right treatment for your weight management goals. At Cured Pharmacy, we offer transparent upfront pricing on all licensed weight loss medications — from Mounjaro at £135.00 to Saxenda at £135.00 — with free clinical consultations by UK-registered prescribers and discreet next-day delivery across the UK.
How Much Do Weight Loss Injections Cost in the UK?
Weight loss injection costs vary significantly depending on the active ingredient, dose strength, and treatment duration. At Cured Pharmacy, Mounjaro (tirzepatide) starts from £135.00 Wegovy (semaglutide) from £135.00 and Saxenda (liraglutide) from £135.00 per prescription cycle. These prices include your medication, free clinical assessment by a UK prescriber, and discreet delivery to your door.
Unlike many online pharmacies that hide pricing until after consultation, we display transparent costs before you begin your assessment. This allows you to make informed decisions about which treatment fits your budget and clinical needs. All prescription weight loss injections require medical approval from our UK-registered clinical team, ensuring safe and appropriate use [1].
Mounjaro Cost Breakdown: Why It's the Most Effective Option
Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management. Starting at £135.00 it represents excellent value when you consider the clinical outcomes. In the SURMOUNT-1 trial, patients achieved an average weight reduction of 22.5% over 72 weeks on the highest maintenance dose — significantly superior to single-pathway alternatives [1][2].
The weekly injection schedule means you administer just four doses per month, and many patients find the dual-action mechanism produces better appetite control and fewer gastrointestinal side effects compared to older GLP-1 treatments. Your UK prescriber will determine your starting dose based on your medical history, BMI, and weight loss goals during the free consultation.
Is Mounjaro Worth the Investment?
When evaluating cost-effectiveness, consider both the clinical data and long-term outcomes. Tirzepatide's dual mechanism targets both GIP and GLP-1 receptors, producing greater reductions in body weight, waist circumference, and metabolic markers compared to semaglutide-only treatments in head-to-head trials [2][3]. For patients who haven't achieved their goals with other medications, Mounjaro often represents the most evidence-based next step, subject to prescriber approval.
Wegovy and Saxenda: Comparing Lower-Cost Alternatives
Wegovy contains semaglutide, a GLP-1 receptor agonist that demonstrated average weight reductions of 14.9% over 68 weeks in the STEP-1 trial [4]. At Cured Pharmacy, Wegovy starts from £135.00 making it a cost-effective option for patients who meet the clinical criteria. The once-weekly injection schedule offers convenience similar to Mounjaro.
Saxenda uses liraglutide, an earlier-generation GLP-1 medication that requires daily injections. Starting from £135.00 it's the most affordable injectable option we offer. Clinical trials showed average weight loss of 8.4 kg over 56 weeks when combined with lifestyle modifications [5]. While the daily injection schedule requires more commitment, many patients appreciate the lower entry cost and the ability to adjust dosing more frequently under prescriber guidance.
Which Injection Offers the Best Value?
Value depends on your individual circumstances, treatment goals, and how your body responds to medication. Patients with higher BMIs or those who haven't responded to lifestyle changes alone often see better outcomes with Mounjaro or Wegovy. Those beginning their weight loss journey or managing modest weight concerns may find Saxenda sufficient and more budget-friendly. Your UK prescriber will recommend the most appropriate option during your free consultation, considering both clinical suitability and cost considerations.
| Treatment | Active Ingredient | Injection Frequency | Starting Price |
|---|---|---|---|
| Mounjaro | Tirzepatide | Once weekly | From £124.99 |
| Wegovy | Semaglutide | Once weekly | From £69.00 |
| Saxenda | Liraglutide | Daily | From £68.00 |
| Wegovy Oral Tablets | Semaglutide | Daily tablet | From £69.00 |
| Orlistat | Orlistat | Three times daily | From £32.00 |
Non-Injectable Options: Orlistat and Oral Semaglutide Costs
Not everyone wants or needs injectable treatments. Orlistat tablets start from £135.00 at Cured Pharmacy, offering a cost-effective alternative that works by blocking fat absorption in the digestive system. Clinical studies demonstrate average weight loss of 2.9 kg more than diet alone over 12 months [6]. Orlistat is particularly suitable for patients who prefer oral medication or have needle anxiety.
We also offer Wegovy Oral Tablets (semaglutide pill) from £135.00 providing the benefits of semaglutide without injections. This newer formulation allows patients who dislike needles to access GLP-1 therapy in tablet form. Xenical (branded orlistat) is available from £135.00, while Alli (lower-dose orlistat) and Orlos offer additional budget-friendly options for patients who meet the clinical criteria.
When to Choose Tablets Over Injections
Oral medications suit patients with needle phobia, those who travel frequently and prefer not to carry injection devices, or individuals managing lower BMI ranges where less intensive intervention may be appropriate. However, injectable GLP-1 treatments typically produce greater weight reductions in clinical trials. Your prescriber will discuss the trade-offs between convenience, cost, and clinical effectiveness to identify the optimal treatment pathway for your circumstances.
Hidden Costs: What Other Pharmacies Don't Tell You
Many online pharmacies advertise attractive starting prices but add consultation fees, delivery charges, or subscription commitments that inflate the total cost. At Cured Pharmacy, our displayed prices include everything: the medication, clinical assessment by a UK-registered prescriber, and discreet delivery. There are no hidden fees or mandatory subscriptions.
We're also transparent about dose escalation. Weight loss injections typically start at lower doses to minimise side effects, then increase gradually over several weeks. Some pharmacies quote only the lowest starter dose, but you'll pay more as your treatment progresses. We show pricing across all dose strengths before you begin, so you can budget accurately for your entire treatment journey. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), ensures every patient receives clear information about ongoing costs during their consultation.
How to Get the Lowest Weight Loss Injection Costs UK
Securing the best value starts with choosing a pharmacy that offers transparent pricing, genuine UK-licensed medications, and qualified clinical oversight. At Cured Pharmacy, we guarantee the lowest prices in the UK on all weight loss treatments. If you find a lower price elsewhere for the same medication and dose, we'll match it.
Start by completing our free online consultation, which takes under three minutes. A UK-registered prescriber will review your medical history, current medications, and weight loss goals to determine the most clinically appropriate and cost-effective treatment. Once approved, your medication is dispensed by our GPhC-registered pharmacy (9012511) and delivered discreetly to your address. Repeat prescriptions are straightforward, with no need to re-complete lengthy assessments unless your clinical circumstances change.
Why Choose Cured Pharmacy for Weight Loss Treatment
We combine clinical expertise with genuine value. Our UK-registered prescribers have assessed thousands of weight loss patients, our pricing is transparent and competitive, and we supply only MHRA-licensed medications from reputable manufacturers. You'll receive ongoing support throughout your treatment, with access to our clinical team if you have questions about side effects, dose adjustments, or treatment progress. Every prescription is reviewed individually to ensure safety and suitability, and we never compromise on clinical standards to reduce costs.
Scientific References
- Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
- Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
- Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
- Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
- Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
- Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
- NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
- NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
- NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.
Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment, lifestyle modifications, and individual metabolic factors.
How it Works?
Select from our recommended UK-licensed medications.
1Choose your treatment

Select safe UK treatments. Quick answers.
2Answer quick questions

We will deliver direct to you as quickly as tomorrow.
3Get it delivered fast

Start Your Assessment For Weight Loss
Start your journey to better health today.
- Reviewed by UK-based prescribers
- Takes under 3 minutes
- Discreet Packaging
Start Your Journey To Better Health Today
Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.
Start My Assessment Log in to Your AccountFaq
Medically reviewed by
Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)
Reviewed on: June 03, 2026
Last updated on 13 August 2026.
Review History
Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.
Why this page was updated on 13 August 2026
Content checked and updated as part of our periodic review, to ensure accuracy and currentness.
Current version (13 August 2026)
Edited by: The Editorial Team
Medically reviewed by:
Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist
How we source info.
When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.